Prudential PLC Medpace Holdings, Inc. Transaction History

Prudential PLC

$19.6 Billion
Q4 2024

A detailed history of Prudential PLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Prudential PLC holds 12,089 shares of MEDP stock, worth $4.14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

12,089

Previous 12,823 5.72%

Holding current value

$4.14 Million

Previous $4.28 Million 6.08%

% of portfolio

0.02%

Previous 0.02%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$308.93 - $363.58 $226,754 - $266,867	-734 Reduced 5.72%	12,089 $4.02 Million
Q3 2024 Nov 12, 2024	SELL	$320.58 - $457.29 $2.23 Million - $3.19 Million	-6,965 Reduced 35.2%	12,823 $4.28 Million
Q2 2024 Aug 06, 2024	SELL	$372.0 - $424.34 $75,888 - $86,565	-204 Reduced 1.02%	19,788 $8.15 Million
Q1 2024 May 14, 2024	SELL	$284.87 - $413.31 $1.22 Million - $1.78 Million	-4,296 Reduced 17.69%	19,992 $8.08 Million
Q4 2023 Feb 13, 2024	BUY	$227.52 - $312.68 $628,410 - $863,622	2,762 Added 12.83%	24,288 $7.45 Million
Q3 2023 Nov 09, 2023	BUY	$233.98 - $281.67 $2.06 Million - $2.48 Million	8,821 Added 69.43%	21,526 $5.21 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $1.51 Million - $1.93 Million	8,042 Added 172.46%	12,705 $3.05 Million
Q1 2023 May 12, 2023	BUY	$174.31 - $239.52 $290,574 - $399,279	1,667 Added 55.64%	4,663 $876,000
Q4 2022 Feb 08, 2023	SELL	$153.06 - $226.57 $57,397 - $84,963	-375 Reduced 11.12%	2,996 $636,000
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $489,233 - $615,173	3,371 New	3,371 $530,000

Others Institutions Holding MEDP

# of Institutions

624

Shares Held

25.1M

Call Options Held

81.2K

Put Options Held

146K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.6B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.

Account